CE Activities

RMEI is dedicated to providing cutting-edge continuing education opportunities for healthcare professionals in order to promote knowledge, awareness, and best practices. We present CE resources in a wide variety of therapeutic areas and formats designed to be both effective and efficient. Most of our activities provide CE credits for physicians, nurses, pharmacists, and members of the multi-disciplinary healthcare team.
Please select the therapeutic area or CE format of interest to you and click "Apply Filter" to see currently available activities.

Therapeutic Areas : Hematology/Oncology, -Small Cell Lung Cancer

This activity offers expert insight into the practice-changing evidence on immunotherapy for the management of extensive-stage small cell lung cancer.

Therapeutic Areas : Hematology/Oncology, -Hematologic Malignancies
CE Format: Online

This enduring activity will provide learners with the latest developments in immunotherapy for leukemia, lymphoma, and myeloma and how these developments can be incorporated into regimens to improve the outcome of patients with these diseases.

Therapeutic Areas : Neuroscience, -Insomnia

This activity provides evidence-based insights, with an emphasis on current gaps in sleep maintenance insomnia. You will learn about the current challenges associated with managing sleep maintenance insomnia and how to utilize currently available and emerging treatments for management, especially in your older and elderly patients.


Therapeutic Areas : Hematology/Oncology, -Hepatocellular Carcinoma

For over a decade, sorafenib was the only systemic agent available for the treatment of advanced hepatocellular carcinoma. However, the past 2.5 years has added 6 additional agents. In this Clinical ForumSM, our multidisciplinary expert roundtable convenes to discuss their collaborative care strategies for first and subsequent line management of advanced hepatocellular carcinoma (HCC) using case-based scenarios.


Therapeutic Areas : Cardiology
CE Format: Online

In this interactive roundtable discussion, Charles, his doctor, and 2 other prominent clinical experts gather to deliberate over reimbursement issues surrounding the clinical use of PCSK9-Is and offer practical strategies to facilitate navigating the prior authorization and appeals process.


Therapeutic Areas : Rheumatology, -Rheumatoid Arthritis
CE Format: Online


Therapeutic Areas : Neuroscience, -Insomnia

In this activity, you will learn about the impact and management of sleep maintenance insomnia, including current approaches as well as novel and emerging treatments.


Therapeutic Areas : Allergy & Immunology, -Chronic Rhinosinusitis

Chronic rhinosinusitis with nasal polyps (CRSwNP) is associated with significant morbidity and negatively impacts quality of life. The good news is that biologic therapies targeting type 2 inflammatory pathways provide additional treatment options for CRSwNP. However, clinicians not only need to accurately diagnose nasal polyps in patients but also recognize the role of the underlying pathology to incorporate biologic agents into treatment regimens when appropriate, as Dr. Joseph K. Han explains.

Therapeutic Areas : Infectious Disease, -Influenza

Most people recover from uncomplicated influenza, but influenza can cause complications that result in severe illness and death. Some patients are at higher risk of experiencing these complications. In this program, physicians specializing in family medicine, internal medicine, and emergency medicine discuss their clinical experience about managing patients who develop symptoms of influenza and are at high risk of complications. They also explain recent changes to national guidelines. A patient who developed symptoms of influenza and was at high risk of complications shares his experience with testing and treatment for influenza.

Therapeutic Areas : Gastroenterology, -Inflammatory Bowel Diseases (IBD)

Join Dr. Sandborn in a virtual demonstration of a clinical decision support tool that assesses disease burden and predicts treatment response for patients with moderate-to-severe Crohn’s Disease.


Therapeutic Areas : Gastroenterology, -Inflammatory Bowel Diseases (IBD)

Join Dr. Dubinsky in a virtual demonstration of a clinical decision support tool that assesses disease burden and predicts treatment response for patients with moderate-to-severe ulcerative colitis.